Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F

By Steimle C.   Lehmann U.   Temerinac S.   Goerttler Ph.   Kreipe H.   Meinhardt G.   Heimpel H.   Pahl H.  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 239-244

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of Hemochromatosis Gene Mutations in 52 Consecutive Patients with Polycythemia Vera

By Franchini Massimo   de Matteis Giovanna   Federici Francesca   Solero Pietro   Veneri Dino  

Hematology, Vol. 9, Iss. 5-6, 2004-10 ,pp. : 413-414

Maney Publishing

Access to resources Recommend Favorite

Fluorescence in Situ Hybridization Analysis of Biomarkers in Cancer

By Mark H.F.L.  

Experimental and Molecular Pathology, Vol. 67, Iss. 3, 1999-12 ,pp. : 131-134

Elsevier

Access to resources Recommend Favorite

Defective expression of the SHP-1 phosphatase in polycythemia vera

By Wickrema A.   Chen F.   Namin F.   Yi T.   Ahmad S.   Uddin S.   Chen Y.-H.   Feldman L.   Stock W.   Hoffman R.   Platanias L.C.  

Experimental Hematology, Vol. 27, Iss. 7, 1999-07 ,pp. : 1124-1132

Elsevier

Access to resources Recommend Favorite

The Role of the Endothelium in the Pathogenesis of Atherosclerosis and its Therapeutic Implications

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 4, 2012-12 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite